Archer Systems LLC

Administer of lien resolution and mass tort settlement programs.

Based in TX

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $50K in lobbying spend across 5 quarterly filings, Archer Systems LLC is an active lobbying client. Their lobbying covers 1 issue area.

$50K
Total Spend
1
Years Active
1
Firms Hired
2
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2023$50K

Issues Lobbied

Medicare/Medicaid

Lobbying Firms

Akin Gump Strauss Hauer & Feld

Lobbyists

Matthew HittleHeide Bajnrauh

Government Agencies Targeted

These are the government entities that Archer Systems LLC disclosed contacting in their lobbying filings.

Centers For Medicare and Medicaid Services (CMS)
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid

The Centers for Medicare & Medicaid Services and resolution of various liens on certain legal settlements.

Issues related to Medicare as Secondary Payer.

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?

Related Investigations

Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Mckesson Corporation & Affiliates U.S. Oncology and Rx Savings Solutions
$22.7M total spend
Doctors Hospital at Renaissance
$4.6M total spend
The University of Texas Md Anderson Cancer Center
$3.5M total spend
Childrens Health System of Texas
$2.8M total spend
Livanova USA, INC.
$2.7M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.